Ignite Creation Date:
2024-05-05 @ 11:23 AM
Last Modification Date:
2024-10-26 @ 9:06 AM
Study NCT ID:
NCT00017303
Status:
UNKNOWN
Last Update Posted:
2013-11-06
First Post:
2001-06-06
Brief Title:
Combination Chemotherapy Plus IM-862 in Treating Patients With Resected Stage III Ovarian Cancer or Primary Peritoneal Cancer
Sponsor:
Cytran
Organization:
National Cancer Institute NCI
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Primary Peritoneal Cavity Cancer |
| Ovarian Cancer |
Keywords:
| Name | View |
|---|---|
| Brenner tumor | View |
| stage III ovarian epithelial cancer | View |
| ovarian undifferentiated adenocarcinoma | View |
| ovarian mixed epithelial carcinoma | View |
| ovarian serous cystadenocarcinoma | View |
| ovarian mucinous cystadenocarcinoma | View |
| ovarian endometrioid adenocarcinoma | View |
| ovarian clear cell cystadenocarcinoma | View |
| primary peritoneal cavity cancer | View |